News J&J says ready to fend off Remicade competitor Pfizer's rival launch should be considered "at risk", says J&J
News Pfizer set for US launch of Remicade biosimilar Pfizer gearing up for US launch late next month.
News J&J's long-lasting diabetes combo approved in US Company looks to new drugs as US Remicade competition looms.
News Sandoz's Enbrel biosimilar approved in US FDA approves first near-copy of inflammatory diseases drug.
News Mylan and Biocon file Herceptin biosimilar in Europe First Herceptin biosimilar filed in EU, companies say.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
